Investors in Ar

Early stage VC based in Prague. Strong founders with profound knowledge of the industry who aims to disrupt with investing in innovations in DACH, Baltics, CEE and UK. They invest in late seed to pre-Series A startups scaling up with 300k ARR. Their investment tickets range from 200k to 2 million. Industry agnostic.

We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.

Springtide Ventures is a venture capital company that helps to bring start-ups to life, materialize their visions, and global ambitions.Springtide Ventures s.r.o., a member of the KKCG group, is a venture capital and private equity firm with a vision to create lasting values through strong partnerships.They invest in SaaS companies specializing in Cyber Security, Cloud Infrastructure.

At Lightbird, we partner, early in the journey, with companies that lead with distribution. We believe that establishing this from the beginning is the only way to stand out in today's market. Backing Entrepreneurs Reaching for the Sky. We are in the era of the end user and their teams, where B2B software companies have to be obsessed with the person they build for. In this era, the best companies turn innovation into a go-to-market advantage. We call this: Distribution Advantage.

Healthcare & Technology Venture Capital since 2001. Vi Partners is the longest-established Swiss Venture Capital firm. For more than 20 years, Vi Partners has been supporting innovative Technology and Healthcare companies, investing over CHF 330m in 66 startups. Vi Partners-managed funds are backed by Switzerland's most visible companies and institutions, including ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva and ZKB as well as the European Investment Fund and many other institutional investors.

An early stage venture capital investment company backing entrepreneurs, who understand that climate change mitigation is not only the responsibility of our generation but also the potentially biggest business opportunity of our time. We are mission-driven entrepreneurs and dedicated doers. We invest in early-stage companies that develop innovative technologies and business models to mitigate climate change and embrace this challenge as an enormous business opportunity.

EquityPitcher is an Early-Growth Venture Capital firm that supports promising startups from the DACH region. Through close cooperation with renowned industry experts, investors and exit partners, we pave the way for entrepreneurs to attain the three decisive success factors: know-how, contacts and capital. The Network-Driven Growth VC. The entire EquityPitcher family is committed to this goal and works side by side with companies every day, supporting them through the effective use of the industry and entrepreneur network.

Since 1998, we at Auriga Partners have supported entrepreneurs from the creation of their company through all stages of development, up to their exit via merger and acquisition or IPO. As pioneers in venture capital in France, we have reinvented ourselves into a multi-specialist investor, dedicated to bringing together specific expertise on future themes or territories—both in unlisted and listed companies.

There are five of us and Patero is our common nest. We come from Logio and we want to improve the world around us. We are all different and we have a simple rule in our genes that when everything comes together in the right proportion, at the right time, in the right place and agrees on something in common, a unique combination is created that changes established principles. We founded our business on the principle of making complex things simpler and more efficient. We rid the world of unnecessary waste. Our mission is to make things nicer, make money and have fun doing it. We associate our business with clear ethical values. Sometimes we invest in a technological miracle and other times we invest in an approach that goes back to traditions and the natural way things work. We are not afraid to connect traditional fields with modern technologies and we believe that it is the merging of different contexts that leads to bigger and better wholes. If we set them up correctly step by step, then we can benefit from them for the whole society.

Alpana Ventures is a Swiss VC focusing on digital transformation. Since 2016 we backed 46 founders' teams, supporting them in their journey towards a positive impact. Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US. We invest to embed them into innovative business models and back them to become global market leaders. Applying ESG criteria, our portfolio companies help create a more sustainable future.

Endeavour Vision is a leading venture capital and growth equity advisory firm focusing on commercial-stage medtech and digital health companies. We support transformative healthcare technologies that provide superior clinical benefits for patients or bring significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Relievant Medsystems, Vertiflex, and Symetis, as well as several IPOs. Endeavour Vision's international investment teams are located in Geneva, Switzerland, Minneapolis, US and San Francisco, US.